echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > New research on repairing blood-brain barrier leads to innovative approach to treating multiple brain diseases

    New research on repairing blood-brain barrier leads to innovative approach to treating multiple brain diseases

    • Last Update: 2022-05-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Neurodegenerative diseases such as traumatic brain injury, stroke, brain tumor or Alzheimer's disease all involve dysfunction of a key player in protecting the brain, the blood-brain barrier (BBB)


    An intact blood-brain barrier acts as a filter between blood and brain tissue, protecting the brain from toxic components in the blood circulation


    A new study in the top academic journal Science shows an innovative approach to repairing the blood-brain barrier


    Previous work has found that the early development and maintenance of the blood-brain barrier is regulated by two secreted protein molecules, Wnt7a and Wnt7b


    A practical problem with this line of thinking, however, is how to improve specificity


    To this end, the research team at the ULB Neuroscience Institute in Belgium developed a special engineered Wnt7a protein


    ▲ According to the special pattern of Wnt7a activating receptors on vascular epithelial cells, the researchers designed Wnt ligands that specifically target the blood-brain barrier (Image source: Reference [1]

    Specifically, the engineered Wnt7a protein (Wnt7a K190A) differs from native Wnt7a by only one amino acid, but this mutation confers the ability to selectively bind the Gpr124/Reck complex


    Using Xenopus laevis, zebrafish, neonatal mice and other animals as models, the researchers first verified that the mRNA encoding the Wnt7a K190A protein did not cause developmental abnormalities even if it was delivered to animals at high doses, providing a safe treatment for it.


    Next, the researchers examined the therapeutic potential of Wnt7a K190A in mouse models of brain tumors and ischemic stroke


    ▲ Schematic diagram of the research on repairing the blood-brain barrier using the modified Wnt7a (Image source: Reference [1]; Credit: Illustration created with BioRender)

    The experiments showed that mice transplanted with glioblastoma cells also had smaller tumors after restoring Wnt signaling in the vascular endothelium and the properties of the blood-brain barrier


    At the end of the paper abstract, the researchers pointed out that this new type of blood-brain barrier therapy can restore the function of the blood-brain barrier by specifically regulating Wnt signaling, bringing potential new treatments for central nervous system diseases


    References:

    [1] Maud Martin et al.


    [2] Andrew McMahon & Justin Ichida (2022) Repairing the blood-brain barrier.


    [3] Method enables blood-brain barrier repair in neurological disorders.


    (Original abridged)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.